Clinical samples were found to overexpress miR-125b in prostate cancer, and enforced expression of miR-125b promoted tumor growth through mediation of broad attenuation of the intrinsic apoptosis pathway by targeting P53, PUMA, and BAK [17]. The gene discussed is BBC3; the disease is prostate cancer.